You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AZD7442

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronavirus Disease 2019 (COVID-19), Healthy Volunteer Trial in Guangzhou, Shanghai (AZD7442 IM, Placebo IM, AZD7442 IV)

Active, not recruiting
  • Coronavirus Disease 2019 (COVID-19)
  • Healthy Volunteer
  • AZD7442 IM
  • +3 more
  • Guangzhou, China
  • +1 more
Jul 27, 2022

COVID-19 Trial in Fukuoka-shi (AZD7442 300 mg IM(male), AZD7442 600 mg IM (male), AZD7442 300 mg IV (male and female))

Completed
  • COVID-19
  • AZD7442 300 mg IM(male)
  • +3 more
  • Fukuoka-shi, Japan
    Research Site
Jun 24, 2022

Coronavirus Disease 2019 (COVID-19) Trial in China (600 mg AZD7442 IV, 600mg IV)

Active, not recruiting
  • Coronavirus Disease 2019 (COVID-19)
  • 600 mg AZD7442 IV
  • 600mg placebo IV
  • Baoding, China
  • +13 more
Jul 12, 2022

Coronavirus Disease 2019 (COVID-19) Trial in United Kingdom, United States (AZD7442 (tixagevimab [AZD8895] + cilgavimab

Active, not recruiting
  • Coronavirus Disease 2019 (COVID-19)
  • AZD7442 (tixagevimab [AZD8895] + cilgavimab [AZD1061])
  • Birmingham, Alabama
  • +15 more
Nov 7, 2022

Corona Virus Disease Trial in United States (AZD7442, AZD8895 (clonal cell line material), AZD1061 (clonal cell line material))

Active, not recruiting
  • Corona Virus Disease
  • AZD7442
  • +4 more
  • Anniston, Alabama
  • +12 more
Aug 12, 2022

A Multi-Centre, Single-arm, Observational Study of EVUSHELD in

Active, not recruiting
  • COVID-19
    • Qionghai, Hainan, China
      (2) Ruijin-Hainan Hospital Shanghai Jiaotong University School o
    Jun 21, 2023

    COVID-19 Trial in Harrow (AZD7442, Placebo)

    Completed
    • COVID-19
    • AZD7442
    • Placebo
    • Harrow, United Kingdom
      Research Site
    Oct 26, 2021

    EVALUATION OF DIFFERENT PROPHYLACTIC INTERVENTIONS TOWARD

    Completed
    • COVID-19 Pandemic
    • Transplant-Related Disorder
    • tixagevimab-cilgavimab(AZD7442, AstraZeneca)
    • Roma, Italy
      Università degli Studi di Roma Tor Vergata
    Dec 17, 2022

    SARS-CoV-2 Trial in Worldwide (AZD7442)

    Recruiting
    • SARS-CoV-2
    • AZD7442
    • Long Beach, California
    • +34 more
    Jan 18, 2023

    PREP (Pre-Exposure Prophylaxis) of COVID-19

    Recruiting
    • Immuno-Deficiency
    • COVID-19
    • Pittsburgh, Pennsylvania
      UPMC
    Aug 9, 2022

    DoD Health System

    Not yet recruiting
    • COVID-19; SARS-CoV-2; 2019 Novel Coronavirus Disease
    • (no location specified)
    Oct 4, 2022

    COVID-19 Trial in United Kingdom, United States (AZD7442, Placebo)

    Completed
    Has Results
    • COVID-19
    • AZD7442
    • Placebo
    • Guntersville, Alabama
    • +56 more
    Oct 24, 2022

    SARS-CoV-2 Infection Trial in United States (Evusheld (tixagevimab+cilgavimab) IM or IV)

    Recruiting
    • SARS-CoV-2 Infection
    • Evusheld (tixagevimab+cilgavimab) IM or IV
    • Fountain Valley, California
    • +33 more
    Jun 24, 2022

    COVID-19 Trial in Worldwide (AZD7442, Placebo)

    Active, not recruiting
    Has Results
    • COVID-19
    • AZD7442
    • Placebo
    • Birmingham, Alabama
    • +85 more
    Nov 25, 2022

    COVID-19 Trial in Worldwide (AZD7442, Placebo)

    Completed
    Has Results
    • COVID-19
    • AZD7442
    • Placebo
    • Jasper, Alabama
    • +102 more
    Jan 14, 2023

    COVID-19, SARS-CoV-2 Trial in Worldwide (AZD5156, Placebo, AZD7442 (EVUSHELD™))

    Recruiting
    • COVID-19, SARS-CoV-2
    • AZD5156
    • +2 more
    • Buenos Aires, Argentina
    • +20 more
    Jan 12, 2023

    COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)

    Active, not recruiting
    • COVID-19
    • AZD7442
    • +2 more
    • Tucson, Arizona
    • +123 more
    Mar 24, 2023

    EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting in

    Recruiting
    • COVID-19
      • Abu Dhabi, United Arab Emirates
      • +1 more
      Jul 20, 2022

      Corona Virus Infection Trial in Worldwide (Remdesivir, Lopinavir/ritonavir, Interferon Beta-1A)

      Active, not recruiting
      • Corona Virus Infection
      • Innsbruck, Austria
      • +61 more
      Jul 1, 2022

      eVusheld Assessment reaL wORld Effectiveness at UPMC

      Not yet recruiting
      • SARS-CoV-2, COVID-19
      • (no location specified)
      Dec 19, 2022

      Israel Clalit Health Services

      Not yet recruiting
      • SARS-CoV-2
      • COVID-19
      • (no location specified)
      Jan 26, 2023

      COVID-19 Trial in United Kingdom (Sotrovimab)

      Recruiting
      • COVID-19
      • Cardiff, United Kingdom
      • +3 more
      Jul 25, 2022

      COVID-19, Immunodeficiency Trial (Paxlovid 5 days, Paxlovid 10 days, Tixagevimab and Cilgavimab)

      Not yet recruiting
      • COVID-19
      • Immunodeficiency
      • Paxlovid 5 days
      • +2 more
      • (no location specified)
      Oct 18, 2022

      Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer Trial in Worldwide (AZD9291 80

      Active, not recruiting
      Has Results
      • Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
      • AZD9291 80 mg/40 mg + placebo
      • +5 more
      • Anaheim, California
      • +168 more
      Nov 29, 2022